These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12935744)
1. Growth of recombinant equine herpesvirus 1 (EHV-1) replaced with passage-induced mutant gene 1 and gene 71 derived from an attenuated EHV-1 in cell cultures and in the lungs of mice. Kirisawa R; Kobayashi T; Uematsu R; Ikeda A; Kuroiwa R; Urakami A; Iwai H Vet Microbiol; 2003 Sep; 95(3):159-74. PubMed ID: 12935744 [TBL] [Abstract][Full Text] [Related]
2. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses. Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037 [TBL] [Abstract][Full Text] [Related]
3. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation]. Neubauer A; Meindl A; Osterrieder N Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185 [TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models. Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880 [TBL] [Abstract][Full Text] [Related]
5. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice. Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844 [TBL] [Abstract][Full Text] [Related]
6. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity. Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896 [TBL] [Abstract][Full Text] [Related]
7. Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model. Frampton AR; Smith PM; Zhang Y; Matsumura T; Osterrieder N; O'Callaghan DJ Virus Res; 2002 Dec; 90(1-2):287-301. PubMed ID: 12457983 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry. Platt R; Sponseller BA; Chiang YW; Roth JA Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862 [TBL] [Abstract][Full Text] [Related]
9. An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice. Marshall KR; Sun Y; Brown SM; Field HJ Virology; 1997 Apr; 231(1):20-7. PubMed ID: 9143298 [TBL] [Abstract][Full Text] [Related]
10. Growth and protective potentials of attenuated strains of equid herpesvirus 1 in the lungs of mice. Kirisawa R; Terada M; Sekiya N; Kawakami Y; Iwai H Zentralbl Veterinarmed B; 1995 Sep; 42(7):391-6. PubMed ID: 8594851 [TBL] [Abstract][Full Text] [Related]
11. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). Rudolph J; O'Callaghan DJ; Osterrieder N J Vet Med B Infect Dis Vet Public Health; 2002 Feb; 49(1):31-6. PubMed ID: 11911590 [TBL] [Abstract][Full Text] [Related]
12. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses. Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016 [TBL] [Abstract][Full Text] [Related]
13. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075 [TBL] [Abstract][Full Text] [Related]
14. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse. Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414 [TBL] [Abstract][Full Text] [Related]
15. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11. von Einem J; Wellington J; Whalley JM; Osterrieder K; O'Callaghan DJ; Osterrieder N J Virol; 2004 Mar; 78(6):3003-13. PubMed ID: 14990719 [TBL] [Abstract][Full Text] [Related]
16. An equine herpesvirus 1 mutant with a lacZ insertion between open reading frames 62 and 63 is replication competent and causes disease in the murine respiratory model. Csellner H; Walker C; Love DN; Whalley JM Arch Virol; 1998; 143(11):2215-31. PubMed ID: 9856103 [TBL] [Abstract][Full Text] [Related]
17. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses. Matsumura T; O'Callaghan DJ; Kondo T; Kamada M Vet Microbiol; 1996 Feb; 48(3-4):353-65. PubMed ID: 9054131 [TBL] [Abstract][Full Text] [Related]
18. Influence of long-term equine herpesvirus type 1 (EHV-1) infection on primary murine neurons-the possible effects of the multiple passages of EHV-1 on its neurovirulence. Cymerys J; Słońska A; Tucholska A; Golke A; Chmielewska A; Bańbura MW Folia Microbiol (Praha); 2018 Jan; 63(1):1-11. PubMed ID: 28409422 [TBL] [Abstract][Full Text] [Related]
19. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus). Fitzpatrick DR; Studdert MJ Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822 [TBL] [Abstract][Full Text] [Related]
20. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection. Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]